Why is $IRON moving today? · SEC 8-K archive

$IRON SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $IRON: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $IRON filing catalyst

Why did $IRON trigger an AI stock catalyst alert?

$IRON triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Disc Medicine Reports Positive Phase 3 APOLLO Trial, Bitopertin NDA Resubmission Planned for Late 2026. Key points: - Phase 3 APOLLO trial of bitopertin met all primary and secondary endpoints in EPP; NDA resubmission planned for end of 2026. - Q3 2026 net loss narrowed to $59.5M ($1.53/share) compared to $62.6M in Q3 2025. - Robust balance sheet with $682.8M in cash and marketable securities as of September 30, 2026.

How did $IRON stock react after the SEC filing?

After the SEC 8-K for $IRON, observed market reaction: T0 price $83.28. Past moves do not guarantee future results.

Where can I get real-time $IRON SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $IRON via Telegram and the VIP Web Terminal from €10/month.

$IRON

$IRON – Disc Medicine Reports Positive Phase 3 APOLLO Trial, Bitopertin NDA Resubmission Planned for Late 2026

Disc Medicine, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $IRON

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

Phase 3 APOLLO trial of bitopertin met all primary and secondary endpoints in EPP; NDA resubmission planned for end of 2026.
Q3 2026 net loss narrowed to $59.5M ($1.53/share) compared to $62.6M in Q3 2025.
Robust balance sheet with $682.8M in cash and marketable securities as of September 30, 2026.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →